Integral Derivatives’s Mead Johnson Nutrition Company MJN Stock Holding History

Integral Derivatives’s Portfolio MJN Stock Details MJN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-23,864	Closed	-$2.13M	–	1384
2017 Q1	$2.13M	Buy	23,864 +1,500	+7%	+$123K	0.04%	293
2016 Q4	$1.58M	Buy	+22,364	New	+$1.67M	0.03%	377
2016 Q3	–	Sell	-2,597	Closed	-$222K	–	1232
2016 Q2	$236K	Buy	+2,597	New	+$220K	0.01%	803
2015 Q2	–	Sell	-2,223	Closed	-$223K	–	1347
2015 Q1	$223K	Sell	2,223 -1,200	-35%	-$121K	﹤0.01%	927
2014 Q4	$344K	Buy	+3,423	New	+$341K	0.01%	1034
2014 Q3	–	Sell	-4,362	Closed	-$413K	–	1632
2014 Q2	$406K	Sell	4,362 -10,771	-71%	-$942K	0.01%	992
2014 Q1	$1.26M	Buy	+15,133	New	+$1.23M	0.02%	581

Other funds holding MJN

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

FNBOO

First National Bank of Omaha Omaha, Nebraska $3.24B AUM 18.68% 1-Year Est. Return

LFAS

Level Four Advisory Services Dallas, Texas $3.05B AUM 23.96% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

CPIG

Chicago Partners Investment Group Chicago, Illinois $4.48B AUM 19.29% 1-Year Est. Return

WEC

Winslow Evans & Crocker Boston, Massachusetts $528M AUM 30.99% 1-Year Est. Return

Integral Derivatives's MJN Position: Q2 2017 in Review

Integral Derivatives sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 23,864 shares — an estimated $2.13M sold.

Integral Derivatives first reported a position in MJN in Q1 2014 and held it in 7 quarters. The position peaked at $2.13M in Q1 2017. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

Integral Derivatives reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
Integral Derivatives sold 23,864 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $2.13M.
Integral Derivatives first reported a position in Mead Johnson Nutrition Company in Q1 2014 and held it in 7 quarters.
Integral Derivatives's Mead Johnson Nutrition Company position peaked at $2.13M in Q1 2017.
7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on Integral Derivatives's 13F filing for Q2 2017, filed 14 Aug 2017.